2Lacombe C. Resistance to erythropoietin[J]. N Engl J Med, 1996,334(10):660-662.
3Rihardson D, Bartlett C, Will El. Intervention thresholds and ceilings can determine the haemoglobin outcome distribution in a haemodialysis population [J]. Nephrol Dial Transplant,2000, 15(12):2007-2013.
4Eschbach JW. Cunent concepts of anemia in chronic renal failure: impact of NKF-DOQI[J].Semin Nephro1,2000,20(4):320.
5Faquin WC, Schneider TJ, Goldbey MA. Effect of inflameutory cytokine on hypoxia-induced erythropoietin production [J].Blood, 1992,79(15): 1987-1994.
6Koury ST, Koury MJ. Erythopoietin production by the kidney[J].Semin Nephrol, 1993,13(1):78-81.
7Descamps Latscha B, Herbelin A, Nguyen AT, et al. Balance between IL-1 beta,TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells and monocytes[J]. J Immunol, 1995,154(2):882-892.
8Fink J, Blahut S, Reddy M , et al. Use of erythropoietin before the initiation of dialysis and its impact on mortality [J]. Am J Kidney Dis, 2001,37(2):348-355.
9Allegra V, Mengozzi G, Vasile A. hon deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three difference into treaments[J]. Nephorn, 1991,57(2):175-182.
10Locatelli F, Andrulli S, Pecchini F ,et al. Effect of high-flux dialysis on the anemia of hemodialysis patients [J]. Nephrol Dial Transplant, 2000,15(9):1399-1409.
